Literature DB >> 30482959

Drug repurposing: Heart failure drug effective in medulloblastoma.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2018        PMID: 30482959     DOI: 10.1038/nrd.2018.213

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma.

Authors:  Lei Huang; Sarah Garrett Injac; Kemi Cui; Frank Braun; Qi Lin; Yuchen Du; Huiyuan Zhang; Mari Kogiso; Holly Lindsay; Sibo Zhao; Patricia Baxter; Adesina Adekunle; Tsz-Kwong Man; Hong Zhao; Xiao-Nan Li; Ching C Lau; Stephen T C Wong
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

  1 in total
  1 in total

Review 1.  Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy.

Authors:  Mehdi Moustaqil; Yann Gambin; Emma Sierecki
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.